- Disease: Acute COVID-19
- Study type: Observational Cohort Study, Treatment
- Study type descriptors: Prospective, Multicentre
- Objective: To analyze the impact of three monoclonal antibody therapies on the genetic evolution of the S gene in high-risk COVID-19 patients by employing next-generation sequencing to detect viral population changes and minority variants emergence
- Number of participants enrolled: 264
- Study enrolling from to
- Study includes follow-up for 1 month
Study Data
- Adults (18-64 years)
- Elderly (≥65 years)
- Fragile population
- Immunocompromised host
- Hospital
- Outpatient clinic
- SARS-CoV-2
- Acute COVID-19
- Pharmacological intervention
- Monoclonal antibodies
- Sotrovimab
- Tixagevimab/Cilgavimab
- Casirivimab/Imdevimab
External Links
Other information
Funders/Sponsors:
- French Ministry of Health Prevention
- French Ministry of Higher Education, Research and Innovation
The information was provided with the aid of the study investigators
If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it
The data is updated up to